A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial
Year: 2022
Type: article
Source: Blood
Authors: Anand P. Jillella, Sandra J. Lee, Jessica K. Altman, Selina M. Luger, Martin S. Tallman, James M. Foran, Lisa Y. Law, Locke J. Bryan, Abdallah Abou Zahr, Kebede Begna, Alexander Perl, Joseph Vadakara, Federico Sanchez, Raymond C. Bergan, Michael J. Fisch, Ruth C. Carlos, Lynne I. Wagner, Mark R. Litzow, Vamsi K. Kota
Institutions: Augusta University, Augusta University Health, Dana-Farber Cancer Institute, Northwestern University, Abramson Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Mayo Clinic in Florida, Kaiser Permanente, Kaiser Permanente Roseville Medical Center, Geisinger Medical Center, Aurora St. Luke's Medical Center, Nebraska Medical Center, University of Nebraska Medical Center, The University of Texas MD Anderson Cancer Center, University of Michigan, U-M Rogel Cancer Center, Wake Forest University Health Sciences, Wake Forest University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4310096186